| 1 | Effectiveness of pharmacist intervention on antidepressant medication knowledge, necessity, and concerns beliefs in patients with depression | 0.5 | 0 | Citations (PDF) |
| 2 | Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019 | 16.5 | 124 | Citations (PDF) |
| 3 | An exploratory study of outpatient medication knowledge and satisfaction with medication counselling at selected hospital pharmacies in Northwestern Nigeria | 2.3 | 11 | Citations (PDF) |
| 4 | Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 | 22.8 | 531 | Citations (PDF) |
| 5 | The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019 | 6.9 | 250 | Citations (PDF) |
| 6 | Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 | 62.1 | 323 | Citations (PDF) |
| 7 | Evaluation of pharmacists’ knowledge in emergency preparedness and disaster management | 0.6 | 8 | Citations (PDF) |
| 8 | Integrating patient safety education into pharmacy curriculum in Nigeria | 0.6 | 3 | Citations (PDF) |
| 9 | Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 | 18.7 | 73 | Citations (PDF) |
| 10 | Public health utility of cause of death data: applying empirical algorithms to improve data quality | 3.1 | 115 | Citations (PDF) |
| 11 | Impact of pharmacist intervention on antidepressant medication adherence and disease severity in patients with major depressive disorder in fragile north-east Nigeria | 0.5 | 5 | Citations (PDF) |
| 12 | Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning | 3.0 | 20 | Citations (PDF) |
| 13 | Hospital pharmacy outpatient medication dispensing and counselling practices in North-Western Nigeria: an observational study | 0.6 | 6 | Citations (PDF) |
| 14 | Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 | 23.3 | 199 | Citations (PDF) |
| 15 | Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990–2019, for 204 countries and territories: the Global Burden of Diseases Study 2019 | 7.9 | 111 | Citations (PDF) |
| 16 | Minimum content of medication counselling for outpatients in North-Western Nigeria—a modified e-Delphi study | 0.5 | 0 | Citations (PDF) |
| 17 | The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017 | 22.8 | 557 | Citations (PDF) |
| 18 | Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017 | 16.5 | 185 | Citations (PDF) |
| 19 | Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017 | 16.5 | 142 | Citations (PDF) |
| 20 | Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 | 62.1 | 16,085 | Citations (PDF) |
| 21 | Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 | 62.1 | 8,078 | Citations (PDF) |
| 22 | Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 | 62.1 | 1,685 | Citations (PDF) |
| 23 | Mapping geographical inequalities in oral rehydration therapy coverage in low-income and middle-income countries, 2000–17 | 13.3 | 34 | Citations (PDF) |
| 24 | Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study | 1.6 | 73 | Citations (PDF) |
| 25 | Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 | 62.1 | 549 | Citations (PDF) |
| 26 | Mapping geographical inequalities in access to drinking water and sanitation facilities in low-income and middle-income countries, 2000–17 | 13.3 | 150 | Citations (PDF) |
| 27 | The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis | 13.3 | 165 | Citations (PDF) |
| 28 | Global injury morbidity and mortality from 1990 to 2017: results from the Global Burden of Disease Study 2017 | 1.6 | 150 | Citations (PDF) |
| 29 | Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 23.3 | 2,013 | Citations (PDF) |
| 30 | Medication safety practices in healthcare facilities in Kaduna State, Nigeria: a study protocol | 2.6 | 4 | Citations (PDF) |
| 31 | Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000–17: analysis for the Global Burden of Disease Study 2017 | 62.1 | 111 | Citations (PDF) |
| 32 | Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 5,545 | Citations (PDF) |
| 33 | The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 22.8 | 1,424 | Citations (PDF) |
| 34 | Falls in older aged adults in 22 European countries: incidence, mortality and burden of disease from 1990 to 2017 | 1.6 | 143 | Citations (PDF) |
| 35 | Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3 | 62.1 | 138 | Citations (PDF) |
| 36 | Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017 | 33.0 | 74 | Citations (PDF) |
| 37 | Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017 | 1.6 | 93 | Citations (PDF) |
| 38 | The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 22.8 | 361 | Citations (PDF) |
| 39 | Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 | 37.9 | 233 | Citations (PDF) |
| 40 | The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 22.8 | 565 | Citations (PDF) |
| 41 | Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 | 7.9 | 471 | Citations (PDF) |
| 42 | Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 | 14.3 | 2,242 | Citations (PDF) |
| 43 | Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050 | 62.1 | 386 | Citations (PDF) |
| 44 | Tracking spending on malaria by source in 106 countries, 2000–16: an economic modelling study | 16.5 | 75 | Citations (PDF) |
| 45 | Diseases, Injuries, and Risk Factors in Child and Adolescent Health, 1990 to 2017 | 8.5 | 207 | Citations (PDF) |
| 46 | Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 17.9 | 2,635 | Citations (PDF) |
| 47 | Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 17.9 | 4,318 | Citations (PDF) |
| 48 | The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017 | 16.5 | 739 | Citations (PDF) |
| 49 | Global, regional, and national burden of epilepsy, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 17.9 | 898 | Citations (PDF) |
| 50 | Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017 | 23.3 | 503 | Citations (PDF) |
| 51 | Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015 | 62.1 | 155 | Citations (PDF) |
| 52 | Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40 | 62.1 | 215 | Citations (PDF) |
| 53 | The Burden of Cardiovascular Diseases Among US States, 1990-2016 | 11.1 | 344 | Citations (PDF) |
| 54 | Denosumab versus bisphosphonates in patients with advanced cancers-related bone metastasis: systematic review and meta-analysis of randomized controlled trials | 2.2 | 56 | Citations (PDF) |
| 55 | The global burden of tuberculosis: results from the Global Burden of Disease Study 2015 | 16.5 | 311 | Citations (PDF) |
| 56 | Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 922 | Citations (PDF) |
| 57 | Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 6,765 | Citations (PDF) |
| 58 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 4,337 | Citations (PDF) |
| 59 | Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 400 | Citations (PDF) |
| 60 | Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 11,792 | Citations (PDF) |
| 61 | Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 439 | Citations (PDF) |
| 62 | Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 | 62.1 | 2,798 | Citations (PDF) |
| 63 | Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study | 16.5 | 238 | Citations (PDF) |
| 64 | Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016 | 34.5 | 1,382 | Citations (PDF) |
| 65 | Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016 | 62.1 | 863 | Citations (PDF) |
| 66 | Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 | 14.3 | 1,452 | Citations (PDF) |
| 67 | Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 2,900 | Citations (PDF) |
| 68 | Global Mortality From Firearms, 1990-2016 | 16.5 | 267 | Citations (PDF) |
| 69 | Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990–2013: findings from the Global Burden of Disease Study 2013 | 6.9 | 101 | Citations (PDF) |
| 70 | Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries | 62.1 | 187 | Citations (PDF) |
| 71 | Evolution and patterns of global health financing 1995–2014: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries | 62.1 | 247 | Citations (PDF) |
| 72 | Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study | 13.3 | 354 | Citations (PDF) |
| 73 | Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 | 14.3 | 4,824 | Citations (PDF) |
| 74 | Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015 | 2.3 | 3,390 | Citations (PDF) |
| 75 | Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015 | 62.1 | 656 | Citations (PDF) |
| 76 | Child and Adolescent Health From 1990 to 2015 | 8.5 | 398 | Citations (PDF) |
| 77 | Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 679 | Citations (PDF) |
| 78 | Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 1,857 | Citations (PDF) |
| 79 | Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 4,292 | Citations (PDF) |
| 80 | Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 7,076 | Citations (PDF) |
| 81 | Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 | 62.1 | 2,198 | Citations (PDF) |
| 82 | Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 17.9 | 2,041 | Citations (PDF) |
| 83 | The Dynamics of Catastrophic and Impoverishing Health Spending in Indonesia: How Well Does the Indonesian Health Care Financing System Perform? | 1.1 | 10 | Citations (PDF) |
| 84 | Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 | 62.1 | 320 | Citations (PDF) |
| 85 | Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 23.3 | 2,078 | Citations (PDF) |
| 86 | Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 988 | Citations (PDF) |
| 87 | Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 1,891 | Citations (PDF) |
| 88 | Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 5,762 | Citations (PDF) |
| 89 | Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 6,295 | Citations (PDF) |
| 90 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 4,791 | Citations (PDF) |
| 91 | Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 | 62.1 | 672 | Citations (PDF) |
| 92 | Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 | 62.1 | 501 | Citations (PDF) |
| 93 | Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015 | 7.9 | 502 | Citations (PDF) |
| 94 | User experience with a health insurance coverage and benefit-package access: implications for policy implementation towards expansion in Nigeria | 2.6 | 7 | Citations (PDF) |
| 95 | Performance evaluation of a health insurance in Nigeria using optimal resource use: health care providers perspectives | 2.5 | 22 | Citations (PDF) |
| 96 | Satisfaction with the level and type of resource use of a health insurance scheme in Nigeria: health management organizations' perspectives | 1.7 | 3 | Citations (PDF) |
| 97 | Assessing responsiveness of health care services within a health insurance scheme in Nigeria: users’ perspectives | 2.5 | 53 | Citations (PDF) |
| 98 | Understanding client satisfaction with a health insurance scheme in Nigeria: factors and enrollees experiences | 2.5 | 64 | Citations (PDF) |
| 99 | The potential of health sector non-governmental organizations: policy options | 2.6 | 103 | Citations (PDF) |
| 100 | Survival of Patients With Sickle Cell Anemia Living at High Altitude | 0.5 | 7 | Citations (PDF) |